Caris Life Sciences, Inc.
CAI NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 5, 2026
ET
EPS Est.
0.01
EPS Actual
0.00
Revenue Est.
$238.1M
Revenue Actual
$263.7M
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
0.03
Revenue Est.
$255.5M
Company Overview
Caris Life Sciences, Inc. (ticker CAI) is listed on NASDAQ with a market cap of about $7.43B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), After-market, with consensus EPS of 0.03. In the last 14 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Nov 1, 2019 → Aug 5, 2026
Nov 1, 2019Range: -0.54 ~ 2.95Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 0.01 | Below forecast↓0.00 | $238.1M | $263.7M |
| May 7, 2026 | -- | -0.02 | Above forecast↑0.00 | $209.4M | $216.2M |
| Feb 26, 2026 | -- | 0.01 | Above forecast↑0.28 | $209.5M | $292.9M |
| Nov 5, 2025 | -- | -0.08 | Above forecast↑0.08 | $174.1M | $216.8M |
| Aug 12, 2025 | -- | -0.21 | Below forecast↓-0.54 | $138M | $181.4M |
| Jun 9, 2025 | -- | -0.22 | Below forecast↓-0.35 | $138M | $120.9M |
| Nov 5, 2021 | -- | 0.61 | Above forecast↑2.95 | $90.2M | $100.8M |
| Aug 3, 2021 | -- | 1.20 | Above forecast↑2.20 | $90.2M | $85.7M |
| Apr 30, 2021 | -- | 1.44 | Above forecast↑2.07 | $85.7M | $80.8M |
| Mar 1, 2021 | -- | 1.47 | Below forecast↓0.80 | $82.5M | $64.3M |
| Nov 2, 2020 | -- | 0.55 | Above forecast↑0.88 | $82M | $79.1M |
| Aug 7, 2020 | -- | 0.72 | Below forecast↓-0.04 | $66.9M | $75.7M |
| May 5, 2020 | -- | 0.29 | Below forecast↓-0.08 | $56.2M | $105M |
| Mar 5, 2020 | -- | 0.33 | Above forecast↑0.45 | $78.4M | $100.2M |
| Nov 1, 2019 | -- | -- | -0.27 | -- | $107.6M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-05 ↗
Earnings Release8-K · 2026-08-05 ↗
Quarterly10-Q · 2026-05-08 ↗
Earnings Release8-K · 2026-05-07 ↗
Annual10-K · 2026-03-03 ↗
Earnings Release8-K · 2026-02-26 ↗
Quarterly10-Q · 2025-11-05 ↗
Earnings Release8-K · 2025-11-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
